Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Antibody Injections Could Be Stepping Stone to HIV Vaccine

May 17, 2016 9:39 am | by Ivy Shih, The Conversation | News | Comments

Imagine a seasonal jab of antibodies that could neutralize the HIV virus.


Improving Natural Killer Cancer Therapy

May 17, 2016 7:30 am | by Vanderbilt University Medical Center | News | Comments

Researchers have discovered a potential way to "tune up" the immune system's ability to kill cancer cells.


HIV Vaccine Design Should Adapt as HIV Virus Mutates

May 17, 2016 7:15 am | by University of Alabama at Birmingham | News | Comments

This process of viral adaptation is constantly occurring, and some adaptations persist even after sequential transmissions to new individuals.


Scientists Identify Potential Marker of EoE Disease Activity

May 16, 2016 3:00 pm | by Cincinnati Children's Hospital Medical Center | News | Comments

Researchers said that measuring EoP blood levels to monitor disease activity has the potential to reduce discomfort, costs and side effects for patients.


New Way to Predict COPD Progression

May 16, 2016 2:00 pm | by American Thoracic Society | News | Comments

The amount of NET complexes in the lungs of patients in the study was directly related to the severity of their COPD and the risk of exacerbations.


J&J CEO: Best of Times, Worst of Times in Healthcare

May 16, 2016 10:16 am | by Ryan Bushey, Digital Editor | Articles | Comments

Alex Gorsky discussed everything from developing new drugs to establishing an appropriate pricing system for these medications.


IBM Macromolecule Kills Ebola, Herpes, Dengue, Influenza in Tests

May 16, 2016 10:14 am | by Seth Augenstein, Digital Reporter | News | Comments

Computing giant IBM has unveiled a new macromolecule-like “molecular Velcro” to kill viruses like Ebola, herpes, dengue and influenza, according to the company.


Pfizer Buying Anacor Pharmaceuticals in $5.2B Deal

May 16, 2016 8:19 am | by The Associated Press | News | Comments

Anacor's stock soared more than 53 percent in Monday premarket trading.


Mylan Strikes $1B Deal for Dermatology Drugs

May 16, 2016 8:05 am | by Ryan Bushey, Digital Editor | Articles | Comments

The acquisition is expected to close by the end of the third quarter.


Patients with Celiac Disease Should Receive Pneumonia Vaccine

May 16, 2016 8:05 am | by Wiley | News | Comments

Researchers have found that patients with celiac disease are at high risk of acquiring pneumonia if they haven't received the pneumococcal vaccine.


Vermont to Require Drug Makes to Explain Price Increases

May 16, 2016 8:04 am | by Dave Gram, Associated Press | News | Comments

Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that's a good idea.


Another Reason for Wine Lovers to Toast Resveratrol

May 16, 2016 8:04 am | by Frontiers | News | Comments

Red wine lovers have a new reason to celebrate. 


Omega-3 Lowers Childhood Aggression in Short-Term

May 16, 2016 8:04 am | by University of Pennsylvania | News | Comments

The Philadelphia randomized control study placed 290 11- and 12-year-olds with a history of violence into four groups.


Pfizer Says It's Blocking Use of Drugs for Lethal Injections

May 16, 2016 7:00 am | by Andrew Welsh-Huggins, Associated Press | News | Comments

The company's announcement has limited immediate impact.


NIH-Led Team Discovers New HIV Vaccine Target

May 16, 2016 6:30 am | by National Institute of Health | News | Comments

A team led by NIH scientists have reported a research trifecta. 



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.